ACell Inc. granted MyungMoon Bio Co. Ltd. exclusive rights to market and distribute its wound management matrix products in South Korea.
Included in the deal are the Cytal and MicroMatrix products, which are comprised of naturally-occurring (porcine derived) urinary bladder matrix (UBM). Both facilitate the remodeling of functional tissue and are indicated for a variety of wounds including partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical sites, trauma wounds (such as abrasions, lacerations, second-degree burns, skin tears), and draining wounds